Status and expression of the p16(INK4) gene in human thyroid tumors and thyroid-tumor cell lines

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 29-34

  Calabrò, Viola ^a   Strazzullo, Maria ^a   La Mantia, Girolama ^a   Fedele, Monica ^b   Paulin, Christian ^c   Fusco, Alfrede ^d   Lania, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MESSENGER RNA; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER GROWTH; CELL CYCLE; CHROMOSOME 9P; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; AMINO ACID SEQUENCE; CELL CULTURE; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; THYROID TUMOR;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 85047679603     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.3.CO;2-P     Document Type: Article

References (31)

1. CAIRNS, P., MAO, L., MERLO, A., LEE, D., SCHWAB, D., EB, Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J. and SIDRANSKY, D., Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-416 (1994).
2. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTONE, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutation and homozygous deletion of the p16 (MTS1) gene in pancreatic adenocardnoma. Nature Genet., 8, 27-32 (1994).
3. CHIAPPETTA, G., BANDIERA, A., BERLINGIERI, M.T., VISCONTI, R., MANFIOLETTI, G., BATTISTA, S., MARTINEZ-TELLO, F.J., SANTORO, M., GIANCOTTI, V. and Fusco, A., The expression of the high-mobility-group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene, 10, 1307-1314 (1995).
4. DONGHI, R., LONGONI, A., PlLOTTI, S., MICHIELI, P., DELLE PORTA, G. and PIEROTTI, M.A., Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. clin. Invest., 91, 1753-1760 (1993).
5. INK4/MTS1-gene transcript expressed in B-cell malignancies. Oncogene, 11, 21-29 (1995).
6. FAGIN, J.A., Molecular pathogenesis of human thyroid neoplasms. Thyroid Today, 17, 1-7 (1994).
7. GRECO, A., PIEROTTI, M.A., BORGANZONE, I., PAGLIARDINI, S., LANZI, C. and DELLA PORTA, G., TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene, 7, 237-242 (1992).
8. HOWES, K.A., RANSOM, N., PAPERMASTER, D.S., LASUDRY, J.G., ALBERT, D.M. and WINDLE, J.J., Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev., 8, 1300-1310 (1994).
9. HUSSUSSIAN, C.J., STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.A.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H., TUCKER, M.A. and DRACOPOLI, N.C., Germline p16 mutations in familial melanoma. Nature Genet., 8, 15-21 (1994).
10. JIN JEN, J., WADE HARPER, J.J., BIGNER, S.H., BIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V., KIRNZLE, K.W. and VOGELSTEIN, B., Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
11. KAMB, A., Cell-cycle regulators and cancer. Trends Genet., 114, 136-140 (1995).
12. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAUTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell-cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
13. LEES, E.M. and HARLOW, E., Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase. Mol. cell. Biol., 13, 1194-1201 (1993).
14. INK4 transcript. Cancer Res., 55, 2995-2997 (1995).
15. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med., 7, 686-692 (1995).
16. MORI, T., MURA, K., AOKI, T., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent somatic mutation of the MTS1 /CDK4I (multiple tumor-suppressor/cyclin-dependent kinase-4 inhibitor)gene in esophageal squamous-cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
17. NAMBA, H., RUBIN, S.A. and FAGIN, J.A., Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol., 4, 1474-1479 (1990).
18. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4-inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
19. INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
20. INK4b genes oncogene, 11, 635-645 (1995).
21. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York (1992).
22. SANTORO, M., CARLOMAGNO, F., HAY, I.D., HERRMANN, M.A., MELILLO, R., BOROANZONE, I., PlEROTTI, M.A., DELLA PORTA, G., BERGER, N., PEIX, J.L., PAULIN, C., FABIEN, N., GRIECO, M., VECCHIO, G., JENKINS, R.B. and Fusco, A., RET-oncogene activation in human thyroid neoplasms is restricted to the papillary-carcinoma sub-type. J. clin. Invest., 89, 1517-1522 (1991).
23. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
24. SPRUCK, C.H. III, GONZALES-ZULUETA, M., SHIBATA, A., SIMONEAU, A.R., LIN, M.F., GONZALES, F., TSAI, Y.C. and JONES, P.A., p16 gene in uncultured tumors. Nature (Lond.), 370, 183-184 (1994).
25. STONE, S., JIANG, P., DAYANANTH, P., TAVTIGIAN, S.V., KATCHER, H., PARRY, D., PETERS, G. and KAMB, A., Complex structure and regulation of the p16 (MTS1) locus. Cancer Res., 55, 2988-2994 (1995).
26. SUN, Y., HILDESHEIM, A., LNIER, A., CAO, Y., YAO, K.T., RAABTRAUB, N. and YANG, C.S., No point mutation but decreased expression of the p16/MTS1 tumor-suppressor gene in nasopharyngeal carcinomas. Oncogene, 10, 785-788 (1995).
27. INK4 in human breast carcinomas. Cancer Res., 54, 5262-5264 (1994).
28. INK4a tumor-suppressor protein. Cancer Res., 55, 2503-2506 (1995).
29. ZHANG, S.Y., KLEIN-SZANTO, A.J.P., SAUTER, E.R., SHAFERENKO, M., MITSUNAGA, S., NABORI, T., CARSON, D.A., RIDGE, J.A. and GOODROW, T.L., Higher frequency of alterations in the p16/CDKN2 gene in squamous-carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 5050-5053 (1994).
30. ZHENG, X.F. and RUDERMANN, J.V., Functional analysis of the P-box, a domain in cyclin B required for the activation of cdc25. Cell, 75, 155-164 (1993).
31. ZHOU, X., TARMIN, L., HAI-YAN JIANG, J.Y., SUZUKI, H., RHYU, M.G., ABRAHAM, J.M. and MELTZER, S.J., The MTS1 gene is frequently mutated in primary esophageal tumors. Oncogene, 9, 3737-3741 (1994).